Regeneron
Phase 3Discover how Regeneron (NASDAQ: REGN) uses the power of science to bring new medicines to patients… over and over again.
Founded
1988
Focus
AntibodiesBiologicsSmall Molecules
About
Discover how Regeneron (NASDAQ: REGN) uses the power of science to bring new medicines to patients… over and over again.
Funding History
1Total raised: $40M
IPO$40MUndisclosedJan 31, 1991
Company Info
TypePrivate
Founded1988
LocationTarrytown, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile